Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06128304 · ClinicalTrials.gov registry record · NA
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
A NA study of HIV and Cervical Cancer, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 2,436
- Enrollment target
- 2
- Study locations
NCT06128304 is a NA study of HIV and Cervical Cancer that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 2,436 participants, above the 432-participant average among 303 other HIV trials with a reported enrollment target (464% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06128304, a NA study of HIV and Cervical Cancer, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,436 participants
- Enrollment target
- 2
- Study locations
Study Summary
While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the health and life expectancy of WLHIV with co-occurring cervical cancer.
Conditions Studied
Interventions
- OTHER Core Implementation strategies
- OTHER Core+ Enhanced Implementation Strategies
Study Locations (2)
California
- UC San Diego - La Jolla
Enugu State
- University of Nigeria, Nsukka - Enugu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,436 participants |
| Start Date | 2023-11-13 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06128304
The ClinicalTrials.gov registry entry for NCT06128304 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,436 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 432-participant average among 303 other HIV trials with a reported enrollment target (464% higher). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Core Implementation strategies is the first listed.
NCT06128304 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Enugu State.
Frequently Asked Questions
What is clinical trial NCT06128304 about?
NCT06128304 is a clinical study titled "ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services". While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available ...
What is the current status of trial NCT06128304?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,436 participants. The study started on 2023-11-13. Estimated completion is 2027-08-31.
What conditions does trial NCT06128304 study?
This clinical trial studies the following conditions: HIV, Cervical Cancer.
What interventions are being tested in trial NCT06128304?
The interventions under investigation include: Core Implementation strategies (OTHER), Core+ Enhanced Implementation Strategies (OTHER).
Who is sponsoring clinical trial NCT06128304?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06128304 being conducted?
This trial has 2 study locations across California, Enugu State. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
-
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.